Screening of Antimicrobial Properties and Bioactive Compounds of Pleurotus Ostreatus Extracts against Staphylococcus Aureus, Escherichia coli, and Neisseria Gonorrhoeae
Table 2
MBC determined for P. ostreatus mushroom extracts antimicrobial properties against target bacteria.
P. ostreatus mushroom extracts
Isolate ID
A
B
C
D
NPS
S. aureus (ATCC 25923)
1 × 10−3 mg/ml
1 × 10−6 mg/ml
1 × 10−1 mg/ml
1 × 10−5 mg/ml
1 × 10−4 mg/ml
E. coli (ATCC 25922)
1 × 10−2 mg/ml
1 × 10−4 mg/ml
1 × 10−3 mg/ml
1 × 10−5 mg/ml
1 × 10−5 mg/ml
N. gonorrhoeae (ATCC 49926)
1 × 10−3 mg/ml
1 × 10−5 mg/ml
1 × 10−2 mg/ml
1 × 10−4 mg/ml
1 mg/ml
ISID 4
1 × 10−3 mg/ml
1 × 10−3 mg/ml
1 × 10−4 mg/ml
1 × 10−6 mg/ml
1 × 10−3 mg/ml
ISID 5
1 × 10−3 mg/ml
1 × 10−5 mg/ml
1 × 10−2 mg/ml
1 × 10−5 mg/ml
1 × 10−4 mg/ml
ISID 7
1 × 10−2 mg/ml
1 × 10−5 mg/ml
1 × 10−1 mg/ml
1 × 10−6 mg/ml
1 × 10−2 mg/ml
ISID 17
1 × 10−4 mg/ml
1 × 10−6 mg/ml
1 × 10−3 mg/ml
1 × 10−4 mg/ml
1 × 10−3 mg/ml
ISID 26
1 × 10−2 mg/ml
1 × 10−3 mg/ml
1 × 10−2 mg/ml
1 × 10−4 mg/ml
1 mg/ml
ISID 28
1 × 10−4 mg/ml
1 × 10−3 mg/ml
1 × 10−5 mg/ml
1 × 10−4 mg/ml
1 × 10−1 mg/ml
ISID 39
1 × 10−4 mg/ml
1 × 10−4 mg/ml
1 × 10−3 mg/ml
1 × 10−5 mg/ml
1 × 10−2 mg/ml
ISID 45
1 × 10−3 mg/ml
1 × 10−4 mg/ml
1 × 10−4 mg/ml
1 × 10−6 mg/ml
1 mg/ml
ISID 55
1 × 10−2 mg/ml
1 × 10−3 mg/ml
1 × 10−2 mg/ml
1 × 10−3 mg/ml
1 × 10−3 mg/ml
P. ostreatus extracts revealed varying degrees of antibacterial activity against the pathogens examined (Table 2). The majority of clinical samples were shown to be most susceptible to extracts B and D and least susceptible to extracts C and NPS.
